PL4065131T3 - Kompozycja do zastosowania doodbytniczego w leczeniu zaparć - Google Patents

Kompozycja do zastosowania doodbytniczego w leczeniu zaparć

Info

Publication number
PL4065131T3
PL4065131T3 PL20815922.8T PL20815922T PL4065131T3 PL 4065131 T3 PL4065131 T3 PL 4065131T3 PL 20815922 T PL20815922 T PL 20815922T PL 4065131 T3 PL4065131 T3 PL 4065131T3
Authority
PL
Poland
Prior art keywords
constipation
treatment
composition
rectal use
rectal
Prior art date
Application number
PL20815922.8T
Other languages
English (en)
Inventor
Cristian Salvatore
Arturo De Meo
Original Assignee
Caprika Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caprika Srl filed Critical Caprika Srl
Publication of PL4065131T3 publication Critical patent/PL4065131T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Insects & Arthropods (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
PL20815922.8T 2019-11-28 2020-10-30 Kompozycja do zastosowania doodbytniczego w leczeniu zaparć PL4065131T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT201900022371 2019-11-28
PCT/IB2020/060209 WO2021105792A1 (en) 2019-11-28 2020-10-30 Rectal-use composition for the treatment of constipation

Publications (1)

Publication Number Publication Date
PL4065131T3 true PL4065131T3 (pl) 2024-12-16

Family

ID=70009126

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20815922.8T PL4065131T3 (pl) 2019-11-28 2020-10-30 Kompozycja do zastosowania doodbytniczego w leczeniu zaparć

Country Status (4)

Country Link
EP (1) EP4065131B1 (pl)
ES (1) ES2992596T3 (pl)
PL (1) PL4065131T3 (pl)
WO (1) WO2021105792A1 (pl)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB917456A (en) * 1958-10-30 1963-02-06 Casco Lab Inc Suppository composition and preparation thereof
CN1026464C (zh) * 1991-12-20 1994-11-09 门清珍 一种肛门栓剂的制备工艺
CA2261787C (en) * 1997-05-30 2006-11-14 Laboratorios Phoenix U.S.A., Inc. Multi-layered osmotic device
EP2403335B1 (en) * 2009-03-03 2014-08-20 Alcon Research, Ltd. Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye
HUP0900353A2 (en) * 2009-06-10 2011-04-28 Egis Gyogyszergyar Nyrt Glycerol-free osmotic type laxative suppository
GB201103942D0 (en) * 2011-03-08 2011-04-20 Norgine Bv Compositions

Also Published As

Publication number Publication date
EP4065131B1 (en) 2024-09-18
WO2021105792A1 (en) 2021-06-03
ES2992596T3 (en) 2024-12-16
EP4065131A1 (en) 2022-10-05

Similar Documents

Publication Publication Date Title
HUS2500039I1 (hu) Elafibranor primer biliáris cirrózis kezelésében történõ alkalmazásra
IL285178A (en) Compounds and uses thereof
EP3990598C0 (en) DETERGENT COMPOSITION
HUE063145T2 (hu) Deuterált vegyületek rákos megbetegedések kezelésében történõ alkalmazásra
IL261721A (en) Combinations of lsd1 inhibitors for use in the treatment of solid tumors
DK3806898T3 (da) Gremlin-1-antagonist til anvendelse i behandling af cancer
HRP20251598T1 (hr) Mavakamten za uporabu u liječenju hipertrofične kardiomiopatije
HUE058931T2 (hu) Pilokarpin hidroklorid alkalmazása presbyopia kezelésére
DK3704108T3 (da) Irak4-hæmmer i kombination med en bcl-2-hæmmer til anvendelse i cancerbehandling
PL3381451T3 (pl) Kompozycja farmaceutyczna stosowana do redukcji zlokalizowanej tkanki tłuszczowej i zastosowanie kompozycji farmaceutycznej
EP3858943A4 (en) Surface treatment agent
PL3972643T3 (pl) Antagoniści układu dopełniacza do stosowania w sposobach leczenia neuropatii paraproteinemicznych
PL3768284T3 (pl) Kompozycje z fageliny entrecoccus do zastosowania w terapii
IL290348A (en) Surface treatment compositions and methods
PL3773589T3 (pl) Inhibitor RET do stosowania w leczeniu raka ze zmianą RET
LT4101454T (lt) Kompozicijos, skirtos naudoti hipertenzijos gydymui
IL289371A (en) Methylthioninium for use in the treatment of synaptopathies
DK4076461T3 (da) Lumateperon til brug ved behandling af skizofreni
EP3630080A4 (en) USE OF EZH2 INHIBITORS TO TREAT CANCER
IL283899A (en) Combinations of a hdm2-p53 interaction inhibitor and a bcl2 inhibitor and their use for treating cancer
IL271464A (en) Nk-1 antagonist compositions and methods for use in treating depression
IT201600121601A1 (it) Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo
IL284514A (en) Halo-allylamine compounds and use thereof
PL3886799T3 (pl) Kompozycje do leczenia utraty włosów
PL3478284T3 (pl) Związki i kompozycje do leczenia nowotworu złośliwego